KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Share-based Compensation (2016 - 2025)

Cme (CME) has disclosed Share-based Compensation for 17 consecutive years, with $28.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Share-based Compensation rose 6.64% to $28.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $94.8 million, a 5.92% increase, with the full-year FY2025 number at $94.8 million, up 5.92% from a year prior.
  • Share-based Compensation was $28.9 million for Q4 2025 at Cme, up from $24.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $28.9 million in Q4 2025 to a low of $15.6 million in Q3 2021.
  • A 5-year average of $21.3 million and a median of $20.2 million in 2023 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: tumbled 34.45% in 2021, then surged 37.1% in 2022.
  • Cme's Share-based Compensation stood at $18.6 million in 2021, then soared by 37.1% to $25.5 million in 2022, then decreased by 4.71% to $24.3 million in 2023, then rose by 11.52% to $27.1 million in 2024, then grew by 6.64% to $28.9 million in 2025.
  • Per Business Quant, the three most recent readings for CME's Share-based Compensation are $28.9 million (Q4 2025), $24.0 million (Q3 2025), and $20.7 million (Q2 2025).